Efficacy and Safety of a 24-Hour Wearable Insulin Delivery Device for Basal-Bolus Therapy in Older Adults

被引:0
|
作者
Zeidan, Trisha
Nikkel, Carla C.
Dziengelewski, Elizabeth A.
机构
关键词
D O I
10.2337/db19-1045-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1045-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] IMPACT TO DIABETES QUALITY PERFORMANCE MEASURES IN AN OLDER ADULT POPULATION WHEN USING A 24-HOUR WEARABLE INSULIN DELIVERY DEVICE FOR BASAL-BOLUS INSULIN THERAPY
    Zeidan, T.
    Nikkel, C.
    Dziengelewski, B.
    [J]. VALUE IN HEALTH, 2019, 22 : S156 - S156
  • [2] Insulin Intensification with a 24-Hour Wearable Insulin Delivery Device in Patients Inadequately Controlled with Basal Insulin Therapy
    Zeidan, Trisha
    Carla, C. Nikkel
    Dziengelewski, Elizabeth A.
    [J]. DIABETES, 2019, 68
  • [3] CLINICAL EFFECTIVENESS OF SWITCHING FROM INSULIN PEN DEVICES TO A 24-HR WEARABLE INSULIN DELIVERY DEVICE IN PATIENTS WITH TYPE 2 DIABETES PRESCRIBED BASAL-BOLUS THERAPY
    Hundal, R.
    Kowalyk, S. Kowalyk
    Cases, J.
    Al-Kardsheh, A.
    Wakim, A. P.
    Doyle, M.
    Spence, A.
    Sink, J.
    Brewer, J.
    Nikkel, C.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A132 - A132
  • [4] Safety and Efficacy of a Novel Basal-Bolus Insulin Delivery Device (IDD) in Adults with T2D Using Rapid-Acting or Regular Human Insulin
    Aronson, Ronnie
    Mahoney, Edward T.
    Saliu, Drilon
    Bergquist, Leya
    Hirsch, Laurence
    [J]. DIABETES, 2019, 68
  • [5] Efficacy and Safety of Oral Semaglutide When Added to Basal, Premix, or Basal-Bolus Insulin
    Mosenzon, Ofri
    Aroda, Vanita R.
    Christiansen, Erik
    Harris, Stewart B.
    Pedersen, Karen Boje
    Tarp-Johansen, Mads Jeppe
    Zinman, Bernard
    [J]. DIABETES, 2020, 69
  • [6] Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
    Zeidan, Trisha
    Nikkel, Carla
    Dziengelewski, Beth
    Wu, Stephanie
    Chen, Aleda M. H.
    [J]. PHARMACY, 2020, 8 (04)
  • [7] Efficacy, Safety, and Usability of a Clinical Decision Support System for Basal-Bolus Insulin Therapy in Hospital Routine Care
    Neubauer, Katharina M.
    Mader, Julia K.
    Aberer, Felix
    Tuca, Alexandru
    Donsa, Klaus
    Augustin, Thomas
    Hoell, Bernhard
    Schaupp, Lukas
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas R.
    [J]. DIABETES, 2016, 65 : A4 - A4
  • [8] EARLY COMBINATION EFFICACY OF VILDAGLIPTIN IN BASAL-BOLUS INSULIN THERAPY WITH METFORMIN: RANDOMIZED CROSSOVER STUDY
    Takeishi, S.
    Tsuboi, H.
    Takekoshi, S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A57 - A57
  • [9] A Clinical Decision Support System for Basal-Bolus Insulin Therapy Is Moving to Hospital Routine Care: Efficacy, Safety, and Usability Confirmed
    Lichtenegger, Katharina M.
    Aberer, Felix
    Tuca, Alexandru C.
    Donsa, Klaus
    Holl, Bernhard
    Schaupp, Lukas
    Plank, Johannes
    Beck, Peter
    Fruhwald, Friedrich
    Pieber, Thomas R.
    Mader, Julia K.
    [J]. DIABETES, 2019, 68
  • [10] Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
    Bergenstal, Richard M.
    Peyrot, Mark
    Dreon, Darlene M.
    Aroda, Vanita R.
    Bailey, Timothy S.
    Brazg, Ronald L.
    Frias, Juan P.
    Johnson, Mary L.
    Klonoff, David C.
    Kruger, Davida F.
    Ramtoola, Shenaz
    Rosenstock, Julio
    Serusclat, Pierre
    Weinstock, Ruth S.
    Naik, Ramachandra G.
    Shearer, David M.
    Zraick, Vivien
    Levy, Brian L.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (05) : 273 - 285